FDA semi-annual agenda
This article was originally published in The Rose Sheet
Executive Summary
Notice of proposed rulemaking for OTC UVA/UVB sunscreens is expected to be released this month, according to FDA's semi-annual agenda, published in an April 24 Federal Register 1notice. Agency anticipated a December 2005 release date for the rule in its last semi-annual agenda (2"The Rose Sheet" Nov. 7, 2005, In Brief). FDA partially stayed the OTC final sunscreen monograph in 2002 to develop UVA/UVB guidelines. Additional items on the semi-annual agenda include releasing NPRM for skin bleaching products this month and NPRM for OTC topical antimicrobial drug products in December. Final action on OTC dandruff, seborrheic dermatitis and psoriasis products is slated for August, and FDA aims to issue technical amendments to the final action on skin protectant products in June...
You may also be interested in...
FDA Proposal Classifies Skin Bleaching Products As Drugs
FDA is proposing a rule that classifies all over-the-counter skin bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register 1notice
FDA semi-annual agenda
A notice of proposed rulemaking for topical antimicrobial consumer products and healthcare antiseptics is slated for release in March, according to FDA's semi-annual agenda, published in Oct. 31 Federal Register. Agency is working to finalize a tentative final monograph for topical antimicrobials published in the June 1994 Federal Register. In October, the Nonprescription Drugs Advisory Committee met to address questions regarding the safety and efficacy of consumer antimicrobials (1"The Rose Sheet" Oct. 24, 2005, p. 9). Additional items on the semi-annual agenda include an amendment to the NPRM for OTC dandruff, seborrheic dermatitis and psoriasis products in December and technical amendments to the final action for skin protectant products marketed as lip protectants in December. The agency expects to release an NPRM for skin bleaching products in March and final action for plaque gingivitis products is slated for October of next year...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.